Related Experiment Video
Updated: Jul 7, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Integrating tuberculosis and HIV care in rural Rwanda
M Gasana1, G Vandebriel, G Kabanda
1Programme National Intégré de Lutte contre la Lèpre et la Tuberculose, Rwandan Ministry of Health, Kigali, Rwanda.
Summary
Integrated tuberculosis (TB) and human immunodeficiency virus (HIV) services in rural Rwanda are feasible. Provider-initiated HIV testing and counselling (PITC) successfully identified high rates of undiagnosed TB among HIV-infected patients.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Global Health
Background:
- Rwanda faces significant burdens from both HIV and TB epidemics.
- A national policy for TB-HIV collaborative activities was established in 2005.
- Integrated care delivery is crucial for managing co-infections.
Purpose of the Study:
- To evaluate the feasibility and outcomes of integrated TB-HIV activities.
- To assess the effectiveness of provider-initiated HIV testing and counselling (PITC) for TB patients.
- To determine the prevalence of undiagnosed TB among in-patients and HIV-infected out-patients.
Main Methods:
- Implementation of PITC for TB patients.
- Standardized TB screening for in-patients and HIV-infected out-patients.
- Retrospective analysis of data from a rural healthcare site (July 2005-June 2006).
Main Results:
- 48% of TB patients were co-infected with HIV.
- PITC acceptance was high among TB patients (87%).
- Undiagnosed TB was prevalent, especially in HIV-infected in-patients (33% of those screened).
Conclusions:
- Integrated TB and HIV services are feasible in rural Rwandan healthcare settings.
- PITC is an effective strategy for TB case finding in TB patients.
- A significant proportion of unrecognised TB exists, particularly among HIV-infected in-patients.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories: